These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular Characterization of Tigecycline Non-Susceptibility among Extensively Drug-Resistant Acinetobacter baumannii Isolates of Clinical Origin. Haeili M, Abdollahi A, Ahmadi A, Khoshbayan A. Chemotherapy; 2021; 66(3):99-106. PubMed ID: 33823517 [Abstract] [Full Text] [Related]
4. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt. Hassan R, Mukhtar A, Hasanin A, Ghaith D. J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486 [Abstract] [Full Text] [Related]
5. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates. Li H, Wang X, Zhang Y, Zhao C, Chen H, Jiang S, Zhang F, Wang H. Future Microbiol; 2015 Apr; 10(3):337-46. PubMed ID: 25812457 [Abstract] [Full Text] [Related]
11. A truncated AdeS kinase protein generated by ISAba1 insertion correlates with tigecycline resistance in Acinetobacter baumannii. Sun JR, Perng CL, Chan MC, Morita Y, Lin JC, Su CM, Wang WY, Chang TY, Chiueh TS. PLoS One; 2012 Apr; 7(11):e49534. PubMed ID: 23166700 [Abstract] [Full Text] [Related]
16. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex. Lin L, Ling BD, Li XZ. Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612 [Abstract] [Full Text] [Related]